| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 08/07/2013 | CN102488827B Preparation method for Yuye decoction lyophilized orally administrated preparation |
| 08/07/2013 | CN102488769B Diet pill |
| 08/07/2013 | CN102429928B Preparation method for coix seed red yeast rice |
| 08/07/2013 | CN102429906B Use of nitrogen heterocyclic compound in preparing drug for inhibiting toxicity of amyloid polypeptide |
| 08/07/2013 | CN102423374B Pharmaceutical composition with antiobesity action |
| 08/07/2013 | CN102406805B Weight-reducing Chinese medicinal preparation |
| 08/07/2013 | CN102366443B Medicine for treating diabetes and preparation method thereof |
| 08/07/2013 | CN102319216B Insulin liposome lyophilized powder, oral insulin compound preparation and preparation methods and applications thereof |
| 08/07/2013 | CN102266472B Chinese medicinal composition for preventing and/or treating diabetic nephropathy and preparation method thereof |
| 08/07/2013 | CN102247413B Hypolipidemic effects of radix dipsaci total saponin and akebia stem saponin D |
| 08/07/2013 | CN102161650B Polyphenol secondary metabolic products in mulberry leaves and preparation method and application thereof |
| 08/07/2013 | CN102056902B Imidazolidine derivatives |
| 08/07/2013 | CN101984034B Health-care wine |
| 08/07/2013 | CN101977910B N-azabicyclic carboxamide derivatives, preparation thereof and therapeutic use thereof |
| 08/07/2013 | CN101653489B Application of Chinese medicinal composition in preparation of medicament for preventing diabetes |
| 08/07/2013 | CN101511208B Method for lowering blood pressure in pre-hypertensive individuals and/or individuals with metabolic syndrome |
| 08/07/2013 | CN101448816B Pieridinyl substituted pyrrolidinones as inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/07/2013 | CN101397315B Tonka bean camphor glycosides compounds, preparation method thereof and medicament composition and use thereof |
| 08/07/2013 | CN101331114B 2-adamantylurea derivatives as selective 11beta-HSD1 inhibitors |
| 08/06/2013 | US8502014 Method for the production of a single heavy chain antibody |
| 08/06/2013 | US8501809 Inhibitors of α4 mediated cell adhesion |
| 08/06/2013 | US8501791 1,2,4-thiadiazolium derivatives as melanocortin receptor modulators |
| 08/06/2013 | US8501737 Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 08/06/2013 | US8501728 Substituted heteroarylamide oxazepinopyrimidone derivatives |
| 08/06/2013 | US8501686 Method of treating fatty liver diseases and conditions in non-lipodystrophic subjects |
| 08/06/2013 | US8501685 Process for preparing peptide products for promoting cholecystokinin secretion and use of the peptide products |
| 08/06/2013 | US8501473 Use of pleitrophin for preventing and treating pancreatic diseases and/or obesity and/or metabolic syndrome |
| 08/06/2013 | US8501240 Compositions comprising an active agent |
| 08/06/2013 | CA2751901C Mineralocorticoid receptor antagonist and methods of use |
| 08/06/2013 | CA2650626C Delivery of active agents using a chocolate vehicle |
| 08/06/2013 | CA2646624C Inhibitors of 11-beta-hydroxysteroid dehydrogenase 1 |
| 08/06/2013 | CA2630624C Compositions and methods for increasing insulin sensitivity |
| 08/06/2013 | CA2629321C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2013 | CA2629223C Glucagon receptor antagonists, preparation and therapeutic uses |
| 08/06/2013 | CA2609388C Novel piperidine derivative |
| 08/06/2013 | CA2567513C Histamine h3 receptor agents, preparation and therapeutic uses |
| 08/06/2013 | CA2556305C Rapidly dissolving solid oral dosage form for delivery of composition for increasing nitric oxide activity |
| 08/06/2013 | CA2451839C Pharmaceutical compositions comprising peptides and permeation enhancers |
| 08/06/2013 | CA2442118C Improved edible compositions for lowering cholesterol |
| 08/06/2013 | CA2368213C Specifically targeted catalytic antagonists and uses thereof |
| 08/01/2013 | WO2013113032A1 G protein-coupled purinergic receptor gpr17 mediates orexigenic effects of foxo1 in agrp neurons |
| 08/01/2013 | WO2013112765A1 Effect of orally administered dipterinyl calcium pentahydrate (dcp) on oral glucose tolerance in dio mice |
| 08/01/2013 | WO2013112663A1 Myonectin (ctrp15), compositions comprising same, and methods of use |
| 08/01/2013 | WO2013112323A1 Phenyl methanesulfonamide derivatives useful as mgat - 2 inhibitors |
| 08/01/2013 | WO2013111924A1 Novel compound derived from ishige foliacea, and use thereof |
| 08/01/2013 | WO2013111918A1 Composition comprising extracts of angelica gigas and wild garlic as active ingredients for preventing or treating diabetes or complications from diabetes |
| 08/01/2013 | WO2013111870A1 Therapeutic agent for diabetes |
| 08/01/2013 | WO2013111823A1 Method for producing sphingoid base-containing extract |
| 08/01/2013 | WO2013111150A1 Derivatives of aza adamantane and uses thereof |
| 08/01/2013 | WO2013110358A1 Hedgehog signaling pathway involved in energy metabolism |
| 08/01/2013 | WO2013110309A1 Triazolo[4,5-d]pyrimidine derivatives |
| 08/01/2013 | WO2009036412A8 Modulators of cystic fibrosis transmembrane conductance regulator |
| 08/01/2013 | US20130197014 Purinone compounds as kinase inhibitors |
| 08/01/2013 | US20130196987 Macrocyclic compounds useful as pharmaceuticals |
| 08/01/2013 | US20130196849 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195960 Substituted Cellulose Acetates and Uses Thereof |
| 08/01/2013 | US20130195834 Treatment of glycogen storage disease type ii |
| 07/31/2013 | EP2620147A2 Compounds of lowering cholesterol |
| 07/31/2013 | EP2620142A1 Hedgehog signaling pathway involved in energy metabolism |
| 07/31/2013 | EP2619203A1 Tricyclic compounds, preparation methods, and their uses |
| 07/31/2013 | EP2619198A1 Modulators of the gpr119 receptor and the treatment of disorders related thereto |
| 07/31/2013 | EP2618827A2 Antidiabetic solid pharmaceutical compositions |
| 07/31/2013 | CN203087461U Lily extraction particle structure capable of promoting proliferation of skin collagen |
| 07/31/2013 | CN103228668A Antidiabetic enolic glucoside of phenylpyruvic acid |
| 07/31/2013 | CN103228644A 4-substituted-cyclohexylamino-4-piperidinyl-acetamide antagonists of CCR2 |
| 07/31/2013 | CN103228642A Crystalline forms of hydrochloride salt of (4a-,9a-s)-1-(1h-benzoimidazole-5-carbonyl)-2,3,4,4a,9,9a-hexahydro-1h-indeno[2,1-b]pyridine-6-carbonitrile and their use as HSD 1 inhibitors |
| 07/31/2013 | CN103228619A Calcium-sensing receptor-active compounds |
| 07/31/2013 | CN103228602A Novel biphenyl compound or pharmaceutically acceptable salt thereof, method for preparing novel biphenyl compound or pharmaceutically acceptable salt thereof, and pharmaceutical composition containing same as active ingredient for preventing or treat |
| 07/31/2013 | CN103228270A A pharmaceutical combination comprising an ileal bile acid transport system (IBAT) inhibitor and a bile acid binder |
| 07/31/2013 | CN103224934A Short interfering ribonucleic acid (siRNA) for oral administration |
| 07/31/2013 | CN103224571A Method for purifying polysaccharide iron complex based on ultrafiltration membrane method |
| 07/31/2013 | CN103224557A Development of long-acting fibroblast growth factor-23 antagonist |
| 07/31/2013 | CN103224532A Cr(III) compound, and preparation method and application thereof |
| 07/31/2013 | CN103224492A 14-aryl-ether andrographolide derivative and preparation method and application thereof |
| 07/31/2013 | CN103223177A Treatment of lipid transport and metabolism gene related diseases by inhibition of natural antisense transcript to a lipid transport and metabolism gene |
| 07/31/2013 | CN103223143A Traditional Chinese medicine composition for treating simple obesity, and preparation method and application thereof |
| 07/31/2013 | CN103223137A Traditional Chinese medicinal preparation for reducing blood sugar |
| 07/31/2013 | CN103223111A Traditional Chinese medicine composition for treating diabetic nephropathy and preparation method thereof |
| 07/31/2013 | CN103223107A Traditional Chinese medicine used for adjusting blood fat and blood pressure, and preparation technology thereof |
| 07/31/2013 | CN103223104A Traditional Chinese medicine composition for treating diabetes and preparation method |
| 07/31/2013 | CN103223087A Food therapy formula for treating diabetes mellitus |
| 07/31/2013 | CN103223057A Medicine used for enhancing insulin sensitivity |
| 07/31/2013 | CN103223047A Medicine for treating hyperlipemia and preparation method thereof |
| 07/31/2013 | CN103223033A Novel natto health-care composite and preparation method and application thereof |
| 07/31/2013 | CN103223026A Traditional Chinese medicine for treating diabetes |
| 07/31/2013 | CN103223024A Diabetes mellitus dialectical traditional Chinese medicine prescription |
| 07/31/2013 | CN103223017A Medicinal composition for treating hyperlipoidemia and preparation method thereof |
| 07/31/2013 | CN103223016A Ginseng, mulberry leaf and chicoric acid composition for treating diabetes |
| 07/31/2013 | CN103222996A Coreopsis tinctoria refined extract and medical application thereof |
| 07/31/2013 | CN103222990A Application of lactobacillus casei and ginkgo leaf extract in preparing medicine used for controlling hyperlipidemia |
| 07/31/2013 | CN103222987A Food mineral supplement capable of effectively treating lupus erythematosus |
| 07/31/2013 | CN103222979A Grape anthocyanin component and pharmacological activity study |
| 07/31/2013 | CN103222964A Orlistat oral preparation and preparation method thereof |
| 07/31/2013 | CN103222963A 生长抑素冻干粉针剂 Somatostatin freeze-dried powder |
| 07/31/2013 | CN103222623A Healthcare cosmetic |
| 07/31/2013 | CN102871971B Freeze-dried powder injection of vitamin B6 and preparation method thereof |
| 07/31/2013 | CN102743379B Composition containing eighteen amino acids and preparation method thereof |
| 07/31/2013 | CN102697826B Gynura divaricata protein extract and preparation method and application thereof |
| 07/31/2013 | CN102614240B Extract containing breviscapine and preparation method thereof |
| 07/31/2013 | CN102526358B Medicinal composition for treating diabetes and preparation method thereof |